Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"

Status:	Active, not recruiting
Conditions:	Peripheral Vascular Disease, Peripheral Vascular Disease, Cardiology
Therapuetic Areas:	Cardiology / Vascular Diseases
Healthy:	No
Age Range:	18 - Any
Updated:	3/31/2019
Start Date:	January 2013
End Date:	December 2022

Peripheral Registry of Endovascular Clinical Outcomes

The PRIME Registry is a multi-center, observational study designed to evaluate immediate and
long-term outcomes (36 months) of endovascular revascularization in patients with critical
limb ischemia (CLI) and advanced peripheral artery disease (PAD).

The Peripheral RegIstry of Endovascular Clinical OutcoMEs (PRIME Registry) represents the
collaborative effort among seven centers across the US with the goal of reaching 10 sites
globally. PRIME explores all aspects of advanced peripheral arterial disease (PAD) and
critical limb ischemia (CLI) care including the collection of comprehensive clinical,
diagnostic, procedural, and follow-up data for three years following an index endovascular
procedure. Data collection activities began in January of 2013 with the goal of collecting
data on 1500 subjects. Analysis of this multi-site registry will produce generalizable
findings that describe the clinical epidemiology and management practices of advanced PAD and
CLI patients.

Inclusion Criteria:

- Patients who are to receive or have received lower extremity endovascular intervention

- Rutherford III-VI Classification

- Ability to provide informed consent within 30 day prior to 60 days post index
endovascular intervention.

- Ability to follow up at enrollment site.

Exclusion Criteria:

- Inability or unwillingness to consent for participation in the registry.

We found this trial at

sites

Prairie Heart

Springfield, Illinois 62701

Principal Investigator: Ashraf Al-Dadah, MD

Phone: 217-492-9100

from

Springfield, IL